PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

27 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Anker, S.D.* et al.: Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451-1461 (2021)
2.
Pitt, B.* et al.: Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N. Engl. J. Med. 385, 2252-2263 (2021)
3.
von Mutius, E. & Martinez, F.D.*: Vitamin D supplementation during pregnancy and the prevention of childhood asthma. N. Engl. J. Med. 382, 574-575 (2020)
4.
Husain, M.* et al.: Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 381, 841-851 (2019)
5.
Körner, A.* ; Tschöp, M.H. & Blüher, M.*: Five-year outcomes of gastric bypass in adolescents as compared with adults. N. Engl. J. Med. 381:e17 (2019)
6.
Neumann, J.T.* et al.: Application of high-sensitivity troponin in suspected myocardial infarction. N. Engl. J. Med. 380, 2529-2540 (2019)
7.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016)
8.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (vol 374, pg 1134, 2016). N. Engl. J. Med. 374, 1898-1898 (2016)
9.
Claussnitzer, M. et al.: FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895-907 (2015)
10.
Nelson, C.P.* et al.: Genetically determined height and coronary artery disease. N. Engl. J. Med. 372, 1608-1618 (2015)
11.
Beuschlein, F.* et al.: Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019-1028 (2014)
12.
TG and HDL Working Group (Crosby, J.R.* ; Peloso, G.M.* ; Auer, P.L.* ; Peters, A. ; Reiner, A.P.* ; Boerwinkle, E.* ; Kathiresan, S.*): Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014)
13.
Liu, E. et al.: Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371, 42-49 (2014)
14.
Navon Elkan, P.* et al.: Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N. Engl. J. Med. 370, 921-931 (2014)
15.
Stand, E.: Saxagliptin, alogliptin, and cardiovascular outcomes. N. Engl. J. Med. 370, 483-484 (2014)
16.
Stitziel, N.O.* et al.: Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371, 2072-2082 (2014)
17.
Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.) et al.: C-reactive protein, fibrinogen, and cardiovascular disease prediction. N. Engl. J. Med. 367, 1310-1320 (2012)
18.
Ebert, M.P.* et al.: TFAP2E-DKK4 and chemoresistance in colorectal cancer. N. Engl. J. Med. 366, 44-53 (2012)
19.
Dolmans, G.H.* et al.: Wnt signaling and Dupuytren's disease. N. Engl. J. Med. 365, 307-317 (2011)
20.
Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.) et al.: Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364, 829-841 (2011)